Anagha Loharikar1, Tiffany A Suragh2, Noni E MacDonald3, Madhava R Balakrishnan4, Oleg Benes5, Smaragda Lamprianou4, Terri B Hyde6, Michael M McNeil2. 1. Global Immunization Division, Centers for Disease Control and Prevention, United States. Electronic address: igd2@cdc.gov. 2. Immunization Safety Office, Centers for Disease Control and Prevention, United States. 3. Dalhousie University, Canada. 4. World Health Organization, Headquarters, Switzerland. 5. World Health Organization, European Region, Denmark. 6. Global Immunization Division, Centers for Disease Control and Prevention, United States.
Abstract
BACKGROUND: Clusters of anxiety-related adverse events following immunization (AEFI) have been observed in several countries and have disrupted country immunization programs. We conducted a systematic literature review to characterize these clusters, to generate prevention and management guidance for countries. METHODS: We searched seven peer-reviewed databases for English language reports of anxiety-related AEFI clusters (≥2 persons) with pre-specified keywords across 4 categories: symptom term, cluster term, vaccine term, and cluster AEFI phenomenon term/phrase. All relevant reports were included regardless of publication date, case-patient age, or vaccine. Two investigators independently reviewed abstracts and identified articles for full review. Data on epidemiologic/clinical information were extracted from full text review including setting, vaccine implicated, predominant case-patient symptoms, clinical management, community and media response, and outcome/impact on the vaccination program. RESULTS: Of 1472 abstracts reviewed, we identified eight published clusters, from all six World Health Organization (WHO) regions except the African Region. Seven clusters occurred among children in school settings, and one was among adult military reservists. The size and nature of these clusters ranged from 7 patients in one school to 806 patients in multiple schools. Patients' symptoms included dizziness, headache, and fainting with rapid onset after vaccination. Implicated vaccines included tetanus (2), tetanus-diphtheria (1), hepatitis B (1), oral cholera (1), human papillomavirus (1), and influenza A (H1N1)pdm09 (2). In each report, all affected individuals recovered rapidly; however, vaccination program disruption was noted in some instances, sometimes for up to one year. CONCLUSIONS: Anxiety-related AEFI clusters can be disruptive to vaccination programs, reducing public trust in immunizations and impacting vaccination coverage; response efforts to restore public confidence can be resource intensive. Health care providers should have training on recognition and clinical management of anxiety-related AEFI; public health authorities should have plans to prevent and effectively manage anxiety-related AEFI clusters. Prompt management of these occurrences can be even more important in an era of social media, in which information is rapidly spread. Published by Elsevier Ltd.
BACKGROUND: Clusters of anxiety-related adverse events following immunization (AEFI) have been observed in several countries and have disrupted country immunization programs. We conducted a systematic literature review to characterize these clusters, to generate prevention and management guidance for countries. METHODS: We searched seven peer-reviewed databases for English language reports of anxiety-related AEFI clusters (≥2 persons) with pre-specified keywords across 4 categories: symptom term, cluster term, vaccine term, and cluster AEFI phenomenon term/phrase. All relevant reports were included regardless of publication date, case-patient age, or vaccine. Two investigators independently reviewed abstracts and identified articles for full review. Data on epidemiologic/clinical information were extracted from full text review including setting, vaccine implicated, predominant case-patient symptoms, clinical management, community and media response, and outcome/impact on the vaccination program. RESULTS: Of 1472 abstracts reviewed, we identified eight published clusters, from all six World Health Organization (WHO) regions except the African Region. Seven clusters occurred among children in school settings, and one was among adult military reservists. The size and nature of these clusters ranged from 7 patients in one school to 806 patients in multiple schools. Patients' symptoms included dizziness, headache, and fainting with rapid onset after vaccination. Implicated vaccines included tetanus (2), tetanus-diphtheria (1), hepatitis B (1), oral cholera (1), human papillomavirus (1), and influenza A (H1N1)pdm09 (2). In each report, all affected individuals recovered rapidly; however, vaccination program disruption was noted in some instances, sometimes for up to one year. CONCLUSIONS: Anxiety-related AEFI clusters can be disruptive to vaccination programs, reducing public trust in immunizations and impacting vaccination coverage; response efforts to restore public confidence can be resource intensive. Health care providers should have training on recognition and clinical management of anxiety-related AEFI; public health authorities should have plans to prevent and effectively manage anxiety-related AEFI clusters. Prompt management of these occurrences can be even more important in an era of social media, in which information is rapidly spread. Published by Elsevier Ltd.
Entities:
Keywords:
AEFI; Mass anxiety; Mass hysteria; Mass psychogenic illness
Authors: Alex Vorsters; Paolo Bonanni; Helena C Maltezou; Joanne Yarwood; Noel T Brewer; F Xavier Bosch; Sharon Hanley; Ross Cameron; Eduardo L Franco; Marc Arbyn; Nubia Muñoz; Mira Kojouharova; Jade Pattyn; Marc Baay; Emilie Karafillakis; Pierre Van Damme Journal: Papillomavirus Res Date: 2019-08-30
Authors: Tiffany A Suragh; Smaragda Lamprianou; Noni E MacDonald; Anagha R Loharikar; Madhava R Balakrishnan; Oleg Benes; Terri B Hyde; Michael M McNeil Journal: Vaccine Date: 2018-08-29 Impact factor: 3.641
Authors: Matthew Butler; Jan Coebergh; Farinaz Safavi; Alan Carson; Mark Hallett; Benedict Michael; Thomas A Pollak; Tom Solomon; Jon Stone; Timothy R Nicholson Journal: J Neuropsychiatry Clin Neurosci Date: 2021-07-15 Impact factor: 2.891
Authors: Syed Hassan Ahmed; Summaiyya Waseem; Taha Gul Shaikh; Nashwa Abdul Qadir; Sarush Ahmed Siddiqui; Irfan Ullah; Abdul Waris; Zohaib Yousaf Journal: Ann Med Surg (Lond) Date: 2022-01-25
Authors: Dong Dong; Richard Huan Xu; Eliza Lai-Yi Wong; Chi-Tim Hung; Da Feng; Zhanchun Feng; Eng-Kiong Yeoh; Samuel Yeung-Shan Wong Journal: Health Expect Date: 2020-10-06 Impact factor: 3.377